News | Proton Therapy | January 25, 2018

IBA Announces First Patient Treated with Proteus Plus in The Netherlands

UMC Groningen Proton Therapy Center treated the first patient on its IBA Proteus Plus within 13 months of installation 

IBA Announces First Patient Treated with Proteus PLUS in The Netherlands

January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG) Proton Therapy Center treated the first patient on its IBA Proteus Plus in January 2018. UMCG successfully treated the first patient within 13 months of installation of the system. This is the first patient to receive proton beam therapy in The Netherlands.

The Proteus Plus at UMCG is configured with two gantry treatment rooms equipped with IBA’s pencil beam scanning (PBS) and cone beam computed tomography (CBCT) large field of view image guidance. These technologies improve the precision of treatment and enable adaptive treatment. The center also benefits from the most advanced room matching available, enabling maximum flexibility of room scheduling and allowing for a minimum 30 percent reduction in commissioning time, therefore, giving maximum flexibility for patient treatment. Rooms are also supplied with IBA’s wireless hand pendant, the only wireless patient remote control in the radiation therapy industry, according to the company, as well as a new-generation, highaccuracy and precision Patient Positioning System.

The UMCG Proton Therapy Center is the first of three centers planned to treat patients in The Netherlands, according to the company.

J.A. Hans Langendijk, Chair, Department of Radiation Oncology at UMCG Proton Therapy Center, added: “In 2009, a team of experts in The Netherlands evaluated the benefits of proton therapy and how to select the patients appropriately. They estimated that over 5800 patients annually could benefit from this cutting-edge cancer treatment in The Netherlands. Three centers are currently being built across the country and we are proud that the UMCG is now the first to deliver proton therapy treatment to patients.

For more information: www.iba-worldwide.com

 

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more